This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
5F-PB-22: Difference between revisions
>Tracer m Added Category:Indole |
>LockPicker m Format |
||
| Line 62: | Line 62: | ||
===Combinational effects=== | ===Combinational effects=== | ||
*'''[[Psychedelics]]''' - When used in combination with psychedelics, cannabinoids are capable of intensifying and extending the duration of both the visual and cognitive effects with extreme efficiency. This should be used with caution if one is not experienced with psychedelics. | *'''[[Psychedelics]]''' - When used in combination with psychedelics, cannabinoids are capable of intensifying and extending the duration of both the visual and cognitive effects with extreme efficiency. This should be used with caution if one is not experienced with psychedelics. | ||
*'''[[Dissociatives]]''' - When used in combination with dissociatives, the geometry, euphoria, dissociation and hallucinatory effects are often greatly enhanced. | *'''[[Dissociatives]]''' - When used in combination with dissociatives, the geometry, euphoria, dissociation and hallucinatory effects are often greatly enhanced. | ||
| Line 84: | Line 85: | ||
==Legal issues== | ==Legal issues== | ||
5F-PB-22 was developed to bypass drug prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world. | 5F-PB-22 was developed to bypass drug prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world. | ||
*''' | |||
*'''China:''' As of October 2015 5F-PB-22 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref> | |||
*'''Germany''' | *'''Germany:''' On December 13, 2014 5F-PB-22 was added to Anlage II of the BtMG, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref><ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html</ref> | ||
*'''Latvia''' | *'''Latvia:''' 5F-PB-22 is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indola-3-karbonskābes esteri) | http://likumi.lv/doc.php?id=121086</ref> | ||
*''' | *'''United Kingdom:''' 5F-PB-22 is a class B drug under the third-generation synthetic cannabinoids generic definition, which came into effect on the 14th December 2016 and is illegal to possess, produce, supply, or import. <ref>The Misuse of Drugs Act 1971 (Amendment) Order 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/uksi/2016/1109/made</ref> | ||
*'''United States:''' In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref> | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[JWH-018]] | *[[JWH-018]] | ||
| Line 97: | Line 100: | ||
*[[Synthetic cannabinoid]] | *[[Synthetic cannabinoid]] | ||
*[[Cannabis]] | *[[Cannabis]] | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/5F-PB-22 5F-PB-22 (Wikipedia)] | *[https://en.wikipedia.org/wiki/5F-PB-22 5F-PB-22 (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=4679 5F-PB-22 (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=4679 5F-PB-22 (Isomer Design)] | ||